JP2019528063A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528063A5
JP2019528063A5 JP2019508929A JP2019508929A JP2019528063A5 JP 2019528063 A5 JP2019528063 A5 JP 2019528063A5 JP 2019508929 A JP2019508929 A JP 2019508929A JP 2019508929 A JP2019508929 A JP 2019508929A JP 2019528063 A5 JP2019528063 A5 JP 2019528063A5
Authority
JP
Japan
Prior art keywords
body fluid
fluid sample
cfdna
amount
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019508929A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019528063A (ja
JP7109424B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/047372 external-priority patent/WO2018035340A1/en
Publication of JP2019528063A publication Critical patent/JP2019528063A/ja
Publication of JP2019528063A5 publication Critical patent/JP2019528063A5/ja
Application granted granted Critical
Publication of JP7109424B2 publication Critical patent/JP7109424B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019508929A 2016-08-17 2017-08-17 体液に基づくセルフリーDNA(cfDNA)アッセイを通して臓器損傷状態を査定するための新規のイムノプローブに基づく方法 Active JP7109424B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662376299P 2016-08-17 2016-08-17
US62/376,299 2016-08-17
PCT/US2017/047372 WO2018035340A1 (en) 2016-08-17 2017-08-17 A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay

Publications (3)

Publication Number Publication Date
JP2019528063A JP2019528063A (ja) 2019-10-10
JP2019528063A5 true JP2019528063A5 (https=) 2020-10-15
JP7109424B2 JP7109424B2 (ja) 2022-07-29

Family

ID=61197090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019508929A Active JP7109424B2 (ja) 2016-08-17 2017-08-17 体液に基づくセルフリーDNA(cfDNA)アッセイを通して臓器損傷状態を査定するための新規のイムノプローブに基づく方法

Country Status (7)

Country Link
US (7) US11124824B2 (https=)
EP (2) EP3845665A1 (https=)
JP (1) JP7109424B2 (https=)
CN (2) CN109890977A (https=)
AU (2) AU2017313138B2 (https=)
CA (1) CA3033650A1 (https=)
WO (1) WO2018035340A1 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
RU2671980C2 (ru) 2011-02-09 2018-11-08 Натера, Инк. Способы неинвазивного пренатального установления плоидности
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
EP4414990A3 (en) 2013-01-17 2024-11-06 Personalis, Inc. Methods and systems for genetic analysis
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
US10125399B2 (en) 2014-10-30 2018-11-13 Personalis, Inc. Methods for using mosaicism in nucleic acids sampled distal to their origin
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
RU2760913C2 (ru) 2016-04-15 2021-12-01 Натера, Инк. Способы выявления рака легкого
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
WO2018022991A1 (en) 2016-07-29 2018-02-01 Streck, Inc. Suspension composition for hematology analysis control
WO2018035340A1 (en) 2016-08-17 2018-02-22 The Regents Of The University Of California A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
CN115119829B (zh) 2017-10-19 2024-07-12 斯特雷克股份有限公司 用于胞外囊泡的溶血和凝血调节以及稳定化的组合物
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
US12024738B2 (en) 2018-04-14 2024-07-02 Natera, Inc. Methods for cancer detection and monitoring
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP4397771A3 (en) * 2019-01-04 2024-10-16 PreAnalytiX GmbH Urine stabilization
EP3914731A1 (en) * 2019-01-24 2021-12-01 Illumina, Inc. Methods and systems for monitoring organ health and disease
JP7470787B2 (ja) 2019-11-05 2024-04-18 パーソナリス,インコーポレイティド 単一試料からの腫瘍純度の推定
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders
EP4263383A4 (en) * 2020-12-17 2024-10-23 Nephrosant, Inc. KITS FOR STABILIZATION OF URINE SAMPLES
EP4373972A4 (en) * 2021-07-23 2025-06-18 Georgetown University USE OF METHYLATED CIRCULATING FREE DNA TO DETECT TISSUE INJURY
WO2023059654A1 (en) 2021-10-05 2023-04-13 Personalis, Inc. Customized assays for personalized cancer monitoring
EP4440429A4 (en) * 2021-11-30 2026-01-28 Nephrosant Inc Generative Antagonist Network for Urinary Biomarkers
US20240124916A1 (en) 2022-09-16 2024-04-18 Illumina Cambridge Limited Nanoparticle with polynucleotide binding site and method of making thereof
WO2025076525A1 (en) * 2023-10-06 2025-04-10 Neutrolis, Inc. Biomarker and precision therapy for inflammatory disease

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0821041B2 (ja) 1988-06-01 1996-03-04 横河電機株式会社 プリント基板cadの部品シンボル作成方法
US5849517A (en) 1991-05-08 1998-12-15 Streck Laboratories, Inc. Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same
JPH0821041A (ja) 1994-07-07 1996-01-23 Ig Tech Res Inc 瓦棒葺屋根の改修構造
US5922544A (en) 1994-12-29 1999-07-13 Eiken Kagaku Kabushiki Kaish Method of cell detection
JPH1021041A (ja) * 1996-06-28 1998-01-23 Matsushita Electric Ind Co Ltd 操作パネル
US7537889B2 (en) * 2003-09-30 2009-05-26 Life Genetics Lab, Llc. Assay for quantitation of human DNA using Alu elements
JP2008545418A (ja) * 2005-05-27 2008-12-18 ジョン ウェイン キャンサー インスティチュート 癌の診断、予後診断、および治療のための遊離循環dnaの使用
US20090081678A1 (en) 2007-09-21 2009-03-26 Streck, Inc. Nucleic acid isolation in preserved whole blood
JP2010017178A (ja) 2008-06-11 2010-01-28 Sumitomo Chemical Co Ltd Dnaを定量又は検出する方法
NO2398912T3 (https=) 2009-02-18 2018-02-10
US8404444B2 (en) 2009-02-25 2013-03-26 Diacarta Llc Method for predicting the level of damage to cells by measuring free circulating Alu nucleic acid
US20110027771A1 (en) 2009-07-31 2011-02-03 Artemis Health, Inc. Methods and compositions for cell stabilization
US20110111410A1 (en) * 2009-11-09 2011-05-12 Streck, Inc. Stabilization of rna in intact cells within a blood sample
JP5763098B2 (ja) * 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
JP5966227B2 (ja) * 2011-02-10 2016-08-10 国立大学法人 長崎大学 急性肺損傷診断方法
JP5214042B2 (ja) 2012-02-03 2013-06-19 アンリツ株式会社 光素子パッケージの製造方法
WO2013173493A1 (en) * 2012-05-15 2013-11-21 Manikkam Suthanthiran Non-invasive method of diagnosing renal fibrosis
WO2014029792A1 (en) 2012-08-21 2014-02-27 Qiagen Gmbh Virus particle stabilisation and method for isolating viral nucleic acids
EP2888363B1 (en) * 2012-08-21 2018-06-06 Qiagen GmbH Method for isolating nucleic acids from a formaldehyde releaser stabilized sample
WO2014074501A1 (en) * 2012-11-06 2014-05-15 Quest Diagnostics Investments Incorporated Molecular markers for diagnosis of acute cellular rejection and acute tubular necrosis
MX2015012733A (es) 2013-03-15 2016-06-21 Immucor Gti Diagnostics Inc Metodos y composiciones para evaluar el estado renal usando adn libre de celulas de la orina.
WO2014146782A1 (en) 2013-03-18 2014-09-25 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
CA2922746A1 (en) * 2013-09-06 2015-03-12 Immucor Gti Diagnostics, Inc. Compositions and methods for diagnosis and prediction of solid organ graft rejection
WO2015159292A2 (en) * 2014-04-14 2015-10-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. A method and kit for determining the tissue or cell origin of dna
WO2015161880A1 (en) 2014-04-24 2015-10-29 Euroclone S.P.A. An in vitro diagnostic method for cancer by means of circulating, cell-free dna
CA3084920C (en) 2014-07-09 2023-02-28 Exosome Diagnostics, Inc. Methods for isolating microvesicles and extracting nucleic acids from biological samples
WO2018031903A1 (en) 2016-08-12 2018-02-15 Streck, Inc. Molecular reference controls
WO2018035340A1 (en) 2016-08-17 2018-02-22 The Regents Of The University Of California A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay

Similar Documents

Publication Publication Date Title
JP2019528063A5 (https=)
Barker et al. Limitations of using feline coronavirus spike protein gene mutations to diagnose feline infectious peritonitis
WO2022271820A1 (en) Spatial detection of sars-cov-2 using templated ligation
CN101407850B (zh) 猴痘病毒的pcr快速检测试剂盒及检测方法
Nicot et al. Diversity of hepatitis E virus genotype 3
CN121575489A (zh) 感染性疾病的检测和预测
JP2008249727A5 (https=)
CN111455114B (zh) SARS-CoV-2的高通量检测试剂盒
CN102791886B (zh) 区分fecv和fipv的工具和方法
CN107541563B (zh) 一种用于早期诊断、预测脓毒血症并发急性肾损伤的分子标记物、试剂盒及应用
CN102181575A (zh) 用于检测乙型肝炎病毒耐药突变位点的引物及方法
CN111187860A (zh) 新型冠状病毒多重pcr快速检测试剂盒
CN105506182B (zh) 一种猪病毒性腹泻病毒5重rt-pcr检测试剂盒
JP2015530868A5 (https=)
Yahyavi et al. Nucleic acid‐based electrochemical biosensor for detection of influenza B by gold nanoparticles
CN107699638A (zh) 一种检测猫杯状病毒的方法
CN104711369A (zh) 高致病性猪蓝耳病病毒的检测引物、探针及检测方法
CN103805717B (zh) 一种用于检测I型和IV型马疱疹病毒的双重Eva Green实时荧光定量PCR检测试剂盒及其应用
CN104774918A (zh) 基于实时荧光pcr的il28b基因多态性检测试剂盒
CN105087826A (zh) 人类免疫缺陷病毒hiv-1的定量检测试剂盒
CN105112568A (zh) 基于焦磷酸测序的鲤春病毒血症病毒检测试剂盒
CN110029160B (zh) 一种基于血浆lncRNA组合物的肺结核病疗效评价试剂盒及其用途
CN102344970A (zh) 同时检测人cmv和bk病毒dna的引物序列及定量检测试剂盒
Tang et al. Identification and genetic characterization of equine Pegivirus in China
JP5845489B2 (ja) B型肝炎ウイルス群を検出し、遺伝子多様性を評価するためのオリゴヌクレオチドのセット、並びにそれを用いた方法